1.Lo JZ, Leow JJ, Ng PL, Lee HQ, Mohd Noor NA, Low JK, Junnarkar SP, Woon WW: Predictors of therapy failure in a series of 741 adult pyogenic liver abscesses. Journal of hepato-biliary-pancreatic sciences 2015, 22(2):156–165.
2.Meddings L, Myers RP, Hubbard J, Shaheen AA, Laupland KB, Dixon E, Coffin C, Kaplan GG: A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends. The American journal of gastroenterology 2010, 105(1):117–124.
3.Tsai FC, Huang YT, Chang LY, Wang JT: Pyogenic liver abscess as endemic disease, Taiwan. Emerging infectious diseases 2008, 14(10):1592–1600.
4.Chen YC, Lin CH, Chang SN, Shi ZY: Epidemiology and clinical outcome of pyogenic liver abscess: an analysis from the National Health Insurance Research Database of Taiwan, 2000–2011. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi 2016, 49(5):646–653.
5.Gallagher MC, Andrews MM: Postdischarge Outcomes of Pyogenic Liver Abscesses: Single-Center Experience 2007–2012. Open forum infectious diseases 2017, 4(3):ofx159.
6.Foo NP, Chen KT, Lin HJ, Guo HR: Characteristics of pyogenic liver abscess patients with and without diabetes mellitus. The American journal of gastroenterology 2010, 105(2):328–335.
7.Li W, Chen H, Wu S, Peng J: A comparison of pyogenic liver abscess in patients with or without diabetes: a retrospective study of 246 cases. BMC gastroenterology 2018, 18(1):144.
8.Masarone M, Rosato V, Aglitti A, Bucci T, Caruso R, Salvatore T, Sasso FC, Tripodi MF, Persico M: Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. PLoS One 2017, 12(6):e0178473.
9.Gonzalez-Regueiro JA, Moreno-Castaneda L, Uribe M, Chavez-Tapia NC: The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes. Ann Hepatol 2017, 16(Suppl. 1: s3–105.):16–21.
10.Mithieux G: Metabolic effects of portal vein sensing. Diabetes Obes Metab 2014, 16 Suppl 1:56–60.
11.Tian LT, Yao K, Zhang XY, Zhang ZD, Liang YJ, Yin DL, Lee L, Jiang HC, Liu LX: Liver abscesses in adult patients with and without diabetes mellitus: an analysis of the clinical characteristics, features of the causative pathogens, outcomes and predictors of fatality: a report based on a large population, retrospective study in China. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18(9):E314–330.
12.Serraino C, Elia C, Bracco C, Rinaldi G, Pomero F, Silvestri A, Melchio R, Fenoglio LM: Characteristics and management of pyogenic liver abscess: A European experience. Medicine 2018, 97(19):e0628.
13.Mukthinuthalapati V, Attar BM, Parra-Rodriguez L, Cabrera NL, Araujo T, Gandhi S: Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital. Dig Dis Sci 2019.
14.Qian Y, Wong CC, Lai S, Chen H, He X, Sun L, Wu J, Zhou J, Yu J, Liu W et al: A retrospective study of pyogenic liver abscess focusing on Klebsiella pneumoniae as a primary pathogen in China from 1994 to 2015. Sci Rep 2016, 6:38587.
15.Poovorawan K, Pan-Ngum W, Soonthornworasiri N, Kulrat C, Kittitrakul C, Wilairatana P, Treeprasertsuk S, Kitsahawong B, Phaosawasdi K: Burden of Liver Abscess and Survival Risk Score in Thailand: A Population-Based Study. The American journal of tropical medicine and hygiene 2016, 95(3):683–688.
16.Thomsen RW, Jepsen P, Sorensen HT: Diabetes mellitus and pyogenic liver abscess: risk and prognosis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2007, 44(9):1194–1201.
17.Jun CH, Yoon JH, Wi JW, Park SY, Lee WS, Jung SI, Park CH, Joo YE, Kim HS, Choi SK et al: Risk factors and clinical outcomes for spontaneous rupture of pyogenic liver abscess. Journal of digestive diseases 2015, 16(1):31–36.
18.Ohishi M: Hypertension with diabetes mellitus: physiology and pathology. Hypertension research: official journal of the Japanese Society of Hypertension 2018, 41(6):389–393.
19.Xu J, Zhou X, Zheng C: The geriatric nutritional risk index independently predicts adverse outcomes in patients with pyogenic liver abscess. BMC geriatrics 2019, 19(1):14.
20.Ruiz-Hernandez JJ, Leon-Mazorra M, Conde-Martel A, Marchena-Gomez J, Hemmersbach-Miller M, Betancor-Leon P: Pyogenic liver abscesses: mortality-related factors. European journal of gastroenterology & hepatology 2007, 19(10):853–858.
21.Thng CB, Tan YP, Shelat VG: Gas-forming pyogenic liver abscess: A world review. Annals of hepato-biliary-pancreatic surgery 2018, 22(1):11–18.
22.Baltzis D, Eleftheriadou I, Veves A: Pathogenesis and treatment of impaired wound healing in diabetes mellitus: new insights. Advances in therapy 2014, 31(8):817–836.
23.Mobasher-Jannat A, Akhavan-Moghadam J: Percutaneous drainage for giant pyogenic liver abscess-does size matter? American journal of surgery 2017, 214(4):770.
24.Ko MC, Lin WH, Martini S, Chang YH, Chiu CT, Li CY: A cohort study of age and sex specific risk of pyogenic liver abscess incidence in patients with type 2 diabetes mellitus. Medicine 2019, 98(17):e15366.
25.Kang SC, Hwang SJ: Impact of advanced age on inpatients with pyogenic liver abscess in Taiwan: a nationwide claim-based analysis. Journal of the Chinese Medical Association: JCMA 2011, 74(12):539–543.